A Study of Subcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Blinatumomab
Related studies linked through entity extraction aliases.
Recombinant Erwinia Asparaginase and Venetoclax in Combination With Blinatumomab for the Treatment of Relapsed or Refractory CD19 Positive B-cell Acute Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE1
TCRαβ-depleted Progenitor Cell Graft With Early Memory T-cell DLI, Plus Selected Use of Blinatumomab, in naïve T-cell Depleted Haploidentical Donor Hematopoietic Cell Transplantation for Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
Blinatumomab Intensification for MRD-Negative Acute B-Cell Lymphoblastic Leukemia Before Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- RECRUITING
- Phase
- NA
Immune-targeted Combination With Chemotherapy for Acute Leukemia of Ambiguous Lineage
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Newly-diagnosed Low Risk Pediatric B-cell ALL Protocol
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Blinatumomab for Treatment of Refractory Myasthenia Gravis
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
NGS MRD-Guided Blinatumomab Treatment for Pediatric B-ALL
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Blinatumomab in Refractory Myasthenia Gravis (BLINA-MG)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
Blinatumomab as Maintenance Therapy in Patients With High-risk B-lineage Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Reduced-Dose Chemo Followed by 14 Days of Blinatumomab for Newly Diagnosed Adult B-ALL Patients: a Multicenter Study
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Study to Investigate Intravenous Blinatumomab in Japanese Adult Participants With Newly Diagnosed Philadelphia-negative B-precursor Acute Lymphoblastic Leukemia (B-ALL)
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
- Status
- RECRUITING
- Phase
- PHASE2
Blinatumomab Plus Venetoclax Sequenced With Inotuzumab Ozogamicin in Treating B-ALL
- Status
- RECRUITING
- Phase
- PHASE2
Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma
- Status
- RECRUITING
- Phase
- PHASE2
The Use of Blinatumomab in Patients With NGS-MRD Relapsed B-ALL After Autologous/Allogeneic Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Blinatumomab Maintenance After Allo-HSCT
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Low-dose Chemotherapy Plus Immuno-targeted Drugs in Newly Diagnosed Adult Ph- B-ALL
- Status
- RECRUITING
- Phase
- PHASE2
Blinatumomab for Relapsed Acute B Lymphoblastic Leukemia After Transplantation
- Status
- RECRUITING
- Phase
- PHASE4